Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-1 plus Cisplatin in Advanced NSCLC
NCT01874678Phase 2Completed
- Sponsor
- TTY Biopharm Company Limited
- Start
- Mar 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in non-small cell lung cancer (NSCLC), sponsored by TTY Biopharm Company Limited. Started Mar 2011; status: completed.
02
Drugs
tegafur
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01874678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01874678.